Immunoassay Analyzer Leasing for Labs
Access automated immunoassay platforms at lower upfront costs—equipment sourced to order
What Is an Immunoassay Analyzer?
Immunoassay analyzers detect and quantify biological markers such as hormones, proteins, and infectious agents using antigen-antibody reactions. They are essential in clinical diagnostics for applications like endocrine testing, tumor markers, cardiac markers, and infectious disease screening. These systems provide sensitive, high-throughput testing critical for accurate diagnosis and patient monitoring.
Why Lease an Immunoassay Analyzer?
From routine hormone panels to STAT infectious disease testing, immunoassay analyzers are vital to timely, accurate diagnostics. But acquiring these platforms—especially those with chemiluminescence, ELISA automation, or integrated sample prep—can require a significant capital investment.
Leasing offers a more flexible, budget-friendly approach. It enables clinical labs, hospitals, and diagnostics providers to adopt or upgrade advanced testing capabilities without delaying timelines or straining capital. As testing menus grow and patient volumes increase, leasing ensures your instrumentation can keep pace.
Where Leasing an Immunoassay Analyzer Adds Value
Immunoassay analyzers are vital for detecting hormones, biomarkers, infectious agents, and more in clinical diagnostics and research. But systems with high throughput, automation, and LIS integration often come with steep upfront costs.
Leasing can be a smart choice when:
- You need lease terms that align with clinical volume or regulatory timelines—Structure payments to match testing demand and compliance goals.
- You want full support from sourcing to validation—Get turnkey setup with equipment delivery, installation, and operational qualification.
- You’re looking to unlock capital from existing systems—Use sale-leaseback options to preserve cash while keeping instruments in service.
Whether you're expanding your test menu or optimizing lab operations, leasing an immunoassay analyzer helps you stay agile, compliant, and financially efficient.
Why Teams Lease with Excedr
Founder-friendly, non-dilutive capital
Ideal for early-stage or venture-backed teams—and a smart option for any lab looking to preserve equity while scaling.
Flexibility on equipment choice
No inventory limitations. You choose the system that fits your workflow—we handle the financing.
Lease terms aligned with your growth
2–5 year terms that support your budget, equipment lifecycle, and scaling timeline.
Quick approvals, flexible terms
Get approved in days—not weeks—with no collateral, IP pledges, or debt covenants required.
White-glove service & procurement
Equipment sourcing, vendor coordination, and lease logistics are streamlined to reduce your team’s internal workload.
Reliable support when it matters
Our vendor relationships help resolve issues quickly—so you stay productive and hit key milestones.
Leasing Solutions We Provide
Operating Leases
Treat lease payments as operating expenses, not debt. This simplifies accounting and preserves flexibility.
Sale Lease-Backs
Convert owned equipment into working capital. Keep it off your balance sheet and treat payments as operating expenses.
Popular Immunoassay Analyzer Manufacturers
Straightforward Application Process
Tell Us What You Need
Already have a quote or PO? Just let us know the equipment you want to lease—we’ll take it from there.
Get Approved Quickly
Our in-house underwriting team reviews your financials fast—no outsourcing, no red tape—so you get a decision in days, not weeks.
We Handle the Rest
We handle the logistics and coordinate with the vendor so you can get to work—no upfront capital required.
Helping Scientists Scale & Succeed
"We used Excedr when it was time for us to make a large capital equipment purchase. The whole leasing process was smooth, quick, and seamless.
Working with Excedr made it possible for us to accelerate our scientific discovery pipeline without a large outlay of capital."
Jessica Grossman
CEO, IgGenix
"Excedr's lease structure helped us extend our cash runway, forecast our projects with greater accuracy, and track and manage upcoming expenses more effectively, putting us in a stronger position for our next venture round."
Shawn Gahr
COO & Co-Founder, Novoron
"Building a biotech is tough, and Excedr has been a dynamite partner in scaling. They supported Distributed Bio’s growth from an 8-person lab team to 35 members by the time of acquisition.
When I started Centivax, Jon was one of the first people I called. I recommend them for any biotech startup."
Jacob Glanville
CEO & President, Centivax
"Excedr has been invaluable for KiraGen Bio, helping us access high-quality equipment without heavy upfront costs.
Their flexible leasing and reliable support let us focus on advancing research rather than equipment procurement and maintenance."
Aaron Edwards
Co-Founder & CEO, KiraGen Bio
"Excedr helped us finance a BLI system when we were new to equipment leasing.
Sylvia guided us through our options, and the fast, easy process freed our team to focus on research and grant management instead of funding logistics."
Max Brennan
General Counsel & VP Operations, Zab Bio
“Leasing our Zeiss EVO10 electron microscope cut outside analysis costs in the first year and improved response times to field issues.
Having it on-site also strengthened our Engineering and Production Teams’ understanding of our product lines."
Tom Raber
Principal Mechanical Technician, Plug Power
Frequently Asked Questions
Lease Immunoassay Analyzers & Accelerate Diagnostic Testing
Don’t let capital limitations delay your testing expansion. Our leasing program is designed to remove friction from equipment procurement so you can stay focused on accuracy, throughput, and patient care.